| Sanofi-Aventis (Suisse) SA - Mutagrip, Suspension zur Injektion | | 00373 | | 20 | | Mutagrip | | Suspension zur Injektion | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 29.07.2011 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like virus: Reass. virus NYMC X-179A) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Perth/16/2009 (H3N2)-like virus: Reass. virus NYMC X-187 from A/Victoria/210/2009) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Brisbane/60/2008) 15 µg.
natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0.05 µg, saccharum nihil, neomycinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension zur Injektion | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
